High-risk patients with locally advanced non-small cell lung cancer treated with stereotactic body radiation therapy to the peripheral primary combined with conventionally fractionated volumetric arc therapy to the mediastinal lymph nodes

High-risk patients with locally advanced non-small cell lung cancer treated with stereotactic body radiation therapy to the peripheral primary combined with conventionally fractionated volumetric arc therapy to the mediastinal lymph nodes

IntroductionA very narrow therapeutic window exists when delivering curative chemoradiotherapy for inoperable locally advanced non-small cell lung cancer (NSCLC), particularly when large distances exist between areas of gross disease in the thorax. In the present study, we hypothesize that a novel t...

Full description

Bibliographic Details
Main Authors: Tanja Eichkorn, Jonathan W. Lischalk, Cedric Stüwe, Eric Tonndorf-Martini, Kai Schubert, Lisa-Antonia Dinges, Sebastian Regnery, Farastuk Bozorgmehr, Laila König, Petros Christopoulos, Juliane Hörner-Rieber, Sebastian Adeberg, Klaus Herfarth, Hauke Winter, Michael Thomas, Stefan Rieken, Jürgen Debus, Rami A. El Shafie
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Oncology
Subjects:
locally advanced non-small cell lung cancer (NSCLC)
peripherally located NSCLC
radiation therapy
dosimetric comparison
pulmonary toxicity
high-risk patients
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.1035370/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.1035370/full

Similar Items